The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Johnna Byrd began taking Zepbound to help her finish the weight loss journey she started. She never imagined it would help ...